Cargando…
Therapeutic potential of α7 nicotinic receptor agonists to regulate neuroinflammation in neurodegenerative diseases
Neurodegenerative diseases, such as Alzheimer's, Parkinson's and Huntington's diseases, are all characterized by a component of innate immunity called neuroinflammation. Neuronal loss and neuroinflammation are two phenomena closely linked. Hence, the neuroinflammation is a relevant ta...
Autores principales: | Foucault-Fruchard, Laura, Antier, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649454/ https://www.ncbi.nlm.nih.gov/pubmed/29089979 http://dx.doi.org/10.4103/1673-5374.215244 |
Ejemplares similares
-
Alpha-7 nicotinic acetylcholine receptor agonist treatment in a rat model of Huntington's disease and involvement of heme oxygenase-1
por: Foucault-Fruchard, Laura, et al.
Publicado: (2018) -
Neuroprotective and anti-inflammatory effects of a therapy combining agonists of nicotinic α7 and σ1 receptors in a rat model of Parkinson’s disease
por: Vetel, Steven, et al.
Publicado: (2020) -
Cholinergic Modulation of Neuroinflammation: Focus on α7 Nicotinic Receptor
por: Piovesana, Roberta, et al.
Publicado: (2021) -
Suppression of neuroinflammation by an allosteric agonist and positive allosteric modulator of the α7 nicotinic acetylcholine receptor GAT107
por: Mizrachi, Tehila, et al.
Publicado: (2021) -
α7 Nicotinic Receptor Agonists: Potential Therapeutic Drugs for Treatment of Cognitive Impairments in Schizophrenia and Alzheimer’s Disease
por: Toyohara, Jun, et al.
Publicado: (2010)